1,622
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

Silicone granuloma mimicking Breast Implant Associated Large Cell Lymphoma (BIA-ALCL): a case report

, , &
Pages 63-67 | Received 18 Oct 2019, Accepted 27 Apr 2020, Published online: 23 May 2020

References

  • DePaola NEK, Coggins H. Breast implant-associated anaplastic large cell lymphoma: what we know. J Adv Pract Oncol. 2019;10(1):54–61.
  • Leberfinger AN, Behar BJ, Williams NC, et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg. 2017;152(12):1161–1168.
  • McCarthy CM, Loyo-Berríos N, Qureshi AA, et al. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): initial report of findings, 2012–2018. Plast Reconstr Surg. 2019;143:65S–73S.
  • Laurent C, Delas A, Gaulard P, et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016;27(2):306–314.
  • Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). n.d. [cited 2019 July 27]. Available from: American Society of Plastic Surgeons website: https://www.plasticsurgery.org/patient-safety/bia-alcl-summary
  • FDA. 2019a. Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL)-letter to health care providers. FDA. Available from http://www.fda.gov/medical-devices/letters-health-care-providers/breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl-letter-health-care-providers
  • Health, C. for D. and R. 2019b. Allergan voluntarily recalls BIOCELL® textured breast implants and tissue expanders. [cited 2019 July 27]. Available from: U.S. Food and Drug Administration website: http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/allergan-voluntarily-recalls-biocellr-textured-breast-implants-and-tissue-expanders
  • Carson B, Cox S, Ismael H. Giant siliconoma mimicking locally advanced breast cancer: a case report and review of literature. Int J Surg Case Rep. 2018;48:54–60.
  • Hillard C, Fowler JD, Barta R, et al. Silicone breast implant rupture: a review. Gland Surg. 2017;6(2):163–168.
  • Napoli AD. Achieving reliable diagnosis in late breast implant seromas: from reactive to anaplastic large cell lymphoma. Plast Reconstr Surg. 2019;143(3S):15S–22S.
  • Hadad E, Klein D, Seligman Y, et al. Sub-muscular plane for augmentation mammoplasty patients increases silicone gel implant rupture rate. J Plast Reconstr Aesthet Surg. 2019;72(3):419–423.
  • Brown SL, Parmentier CM, Woo EK, et al. Silicone gel breast implant adverse event reports to the Food and Drug Administration, 1984–1995. Public Health Rep. 1998;113(6):535–543.
  • Grubstein A, Cohen M, Steinmetz A, et al. Siliconomas mimicking cancer. Clin Imaging. 2011;35(3):228–231.
  • D’hulst L, Nicolaij D, Beels L, et al. False-positive axillary lymph nodes due to silicone adenitis on (18)F-FDG PET/CT in an oncological setting. J Thorac Oncol. 2016;11(6):e73–e75.
  • Marra A, Viale G, Pileri SA, et al. Breast implant-associated anaplastic large cell lymphoma: a comprehensive review. Cancer Treat Rev. 2020;84:101963. Epub 2020 Jan 13. Review.